Evidence map›Paper›PMID 41079016›Full record

ArticleAmerican journal of ophthalmology case reports2025

A case of atypical retinopathy of prematurity with coexisting occlusive vasculitis.

Ji Hye Jang

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ji Hye JangDepartment of Ophthalmology, Keimyung University School of Medicine, Daegu, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To report an atypical case of retinopathy of prematurity (ROP) presenting with severe retinal vascular changes in a preterm infant who did not meet conventional criteria for aggressive ROP. Observations: A male infant, born at 32 weeks and 6 days of gestation with a birth weight of 1400 g, developed significant retinal changes by 4 weeks of postnatal age. Fundus examination revealed bilateral severe plus disease, flat neovascularization, multiple retinal hemorrhages, severe vascular sheathing, extensive perivascular deposits, and arteriovenous shunting within zone I. These findings were atypical and resembled occlusive vasculitis, differing from classical aggressive ROP. During hospitalization, he received non-invasive oxygen therapy for 13 days, with oxygen saturation in the target range of 90-94 %. Although his general condition remained stable and there were no signs of infection, serum interleukin-6 levels were elevated at birth, suggesting possible perinatal inflammation. Intravitreal ranibizumab (0.2 mg) was administered on the day of diagnosis. Retinal vascular abnormalities gradually resolved over 4 weeks following treatment. No recurrence or complications were observed up to a postmenstrual age of 70 weeks. Conclusions and importance: This case shows that severe and unusual retinal changes can develop even in premature infants who are not considered high risk for aggressive ROP based on gestational age or birth weight.Fluctuations in oxygen levels and inflammation may play a role in these unusual forms of ROP, and further research is needed to better understand these causes.

Indexed as

Atypical ROPIL-6Interleukin 6OxygenRanibizumabRetinopathy of prematurity

Identifiers

PMID41079016
PMCPMC12514352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.